paclitaxel has been researched along with Erythema Multiforme in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, PR | 1 |
Buzdar, A; Cohen, PR; Dhingra, K; Gagel, R; Holmes, F; Payne, JY | 1 |
Hirai, K; Ishii, M; Ishiko, O; Kanaoka, Y; Nakajima, S; Nakamura, Y; Ogita, S; Oiso, N | 1 |
3 other study(ies) available for paclitaxel and Erythema Multiforme
Article | Year |
---|---|
Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Erythema Multiforme; Female; Humans; Middle Aged; Nail Diseases; Paclitaxel; Photosensitivity Disorders; Sunlight | 2009 |
Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Eruptions; Erythema Multiforme; Female; Humans; Hyperbilirubinemia; Hypercalcemia; Liver Neoplasms; Middle Aged; Mouth Diseases; Neoplasm Proteins; Paclitaxel; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; Vaginal Diseases | 1996 |
Local erythematous dermatitis after intravenous docetaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Eruptions; Erythema Multiforme; Female; Firearms; Humans; Infusions, Intravenous; Ovarian Neoplasms; Paclitaxel; Taxoids | 2002 |